In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Inflammation and cardiovascular disease
Session

Event : ESC Congress 2017

Topic : Lipids

  • Session type : Debate Session
  • Date : 28 August 2017
  • Time : 13:00 - 14:30

7 presentations in this session

Positioning of the topic - Inflammation and cardiovascular disease

Event : ESC Congress 2017

  • Session : Inflammation and cardiovascular disease
  • Speaker : TF Luscher (London,GB)

Inflammation plays a key role in coronary artery disease - PRO

Event : ESC Congress 2017

  • Session : Inflammation and cardiovascular disease
  • Speaker : PM Ridker (Boston,US)

Inflammation plays a key role in coronary artery disease - CON

Event : ESC Congress 2017

  • Session : Inflammation and cardiovascular disease
  • Speaker : A Catapano (Milan,IT)

Inflammation plays a key role in coronary artery disease - Rebuttal PRO.

Event : ESC Congress 2017

  • Session : Inflammation and cardiovascular disease
  • Speaker : PM Ridker (Boston,US)

Inflammation plays a key role in coronary artery disease - Rebuttal CON

Event : ESC Congress 2017

  • Session : Inflammation and cardiovascular disease
  • Speaker : A Catapano (Milan,IT)

Inflammation and cardiovascular disease - Moderated discussion

Event : ESC Congress 2017

  • Session : Inflammation and cardiovascular disease

Inflammation and cardiovascular disease - Conclusion.

Event : ESC Congress 2017

  • Session : Inflammation and cardiovascular disease
  • Speaker : F Crea (Roma,IT)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are